HYPERSTAT Drug Patent Profile
✉ Email this page to a colleague
When do Hyperstat patents expire, and what generic alternatives are available?
Hyperstat is a drug marketed by Schering and is included in one NDA.
The generic ingredient in HYPERSTAT is diazoxide. There are five drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the diazoxide profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Hyperstat
A generic version of HYPERSTAT was approved as diazoxide by E5 PHARMA INC on December 20th, 2019.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for HYPERSTAT?
- What are the global sales for HYPERSTAT?
- What is Average Wholesale Price for HYPERSTAT?
Summary for HYPERSTAT
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 112 |
| Patent Applications: | 4,558 |
| DailyMed Link: | HYPERSTAT at DailyMed |
US Patents and Regulatory Information for HYPERSTAT
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Schering | HYPERSTAT | diazoxide | INJECTABLE;INJECTION | 016996-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
